Spyre Therapeutics, Inc. Share Price
SYRESpyre Therapeutics, Inc. Stock Performance
Open $34.01 | Prev. Close $32.94 | Circuit Range N/A |
Day Range $33.23 - $34.92 | Year Range $10.91 - $35.05 | Volume 4,749 |
Average Traded $33.59 |
Spyre Therapeutics, Inc. Share Price Chart
About Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD). It develops SPY001, a human monoclonal immunoglobulin G1 antibody designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease). The company is developing SPY002, a human monoclonal antibody (mAb)candidates designed to bind to tumor necrosis factor-like ligand 1A; and SPY120, a combination of SPY001 (anti-a4ß7) and SPY002 (anti-TL1A) antibodies, which are in preclinical studies. In addition, its other early-stage programs include SPY003, an anti-IL-23 mAb; SPY004; SPY130, a combination of anti-a4ß7 and anti-IL-23 mAbs; and SPY230, a combination of anti-TL1A and anti-IL-23 mAbs. The company was formerly known as Aeglea BioTherapeutics, Inc. and changed its name to Spyre Therapeutics, Inc. in November 2023. The company was incorporated in 2013 and is based in Waltham, Massachusetts.
Spyre Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
04-Feb-26 | $33.45 | $32.12 | -3.43% |
03-Feb-26 | $33.53 | $33.26 | +1.56% |
02-Feb-26 | $31.50 | $32.75 | +2.44% |
30-Jan-26 | $33.40 | $31.97 | -4.51% |
29-Jan-26 | $33.13 | $33.48 | +1.07% |
28-Jan-26 | $33.80 | $33.13 | -0.64% |
27-Jan-26 | $32.43 | $33.34 | +3.48% |
FAQs on Spyre Therapeutics, Inc. Share Price
Can I buy Spyre Therapeutics, Inc. shares in India?
What is the share price of Spyre Therapeutics, Inc.?
What is the 5 year returns of Spyre Therapeutics, Inc.?
What are the high & low stock price of Spyre Therapeutics, Inc. today?
What is the 52-week high and low of Spyre Therapeutics, Inc. stock?